Literature DB >> 19870262

LYMPHOMATOSIS, MYELOMATOSIS, AND ENDOTHELIOMA OF CHICKENS CAUSED BY A FILTERABLE AGENT : II. MORPHOLOGICAL CHARACTERISTICS OF THE ENDOTHELIOMATA CAUSED BY THIS AGENT.

J Furth1.   

Abstract

When stimulated by a filterable agent of leukosis of chickens (Strain 2), endothelium may undergo seemingly unrestricted growth. These neoplasms of endothelium are usually unaccompanied by the formation of blood cells. Occasionally they produce hemocytoblasts, discharged like those of the normal marrow into vascular channels as also myelocytes about the vessels. The same agent that stimulates endothelium also stimulates erythroblasts, myelocytes, and hemocytoblasts to unrestricted growth without obviously affecting the endothelium; and the association of endothelioma and leukosis is the result of stimulation of several types of cells by a single virus. Myelocytes appear also to develop from mesenchymal or endothelial cells without the intermediary stage of hemocytoblasts. It is often impossible to determine whether the neoplasms caused by the virus of Strain 2 are of endothelial or mesenchymal origin, and it is possible that both types of cells may be stimulated by the same virus. Types of sarcoma like those described by Rous are not produced by the virus of Strain 2.

Entities:  

Year:  1934        PMID: 19870262      PMCID: PMC2132326          DOI: 10.1084/jem.59.4.501

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  Studies on the Pathogenesis of Erythroleucosis.

Authors:  H L Ratcliffe; J Furth
Journal:  Am J Pathol       Date:  1933-03       Impact factor: 4.307

2.  LYMPHOMATOSIS, MYELOMATOSIS, AND ENDOTHELIOMA OF CHICKENS CAUSED BY A FILTERABLE AGENT : I. TRANSMISSION EXPERIMENTS.

Authors:  J Furth
Journal:  J Exp Med       Date:  1933-08-31       Impact factor: 14.307

  2 in total
  1 in total

1.  THE RELATION OF LEUKOSIS TO SARCOMA OF CHICKENS : II. MIXED OSTEOCHONDROSARCOMA AND LYMPHOMATOSIS (STRAIN 12).

Authors:  J Furth
Journal:  J Exp Med       Date:  1936-01-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.